- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06797843
Clinical Evaluation of Bioactive Resin Composites Versus Caries Control Technique in Management of Class I Carious Cavities in High Caries Risk Patients: a Randomized Clinical Trial
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Sara M Khalil, Bachelor Degree(BDS)
- Phone Number: +20-2(01008927568)
- Email: sara-mansour@dentistry.cu.edu.eg
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Patient inclusion:
- Adult Patients (Male or Females) aging ≥21-50 years.
- Patients with high level of caries risk.
- Patients with good likelihood of recall availability.
Tooth inclusion:
1- Permanent posterior molar teeth with primary simple occlusal Class I carious lesions (ICDAS 3 or 4 scores) 3- 2- Vital, periodontally sound and with positive reaction to cold stimulus. 4- 3-Well-formed and fully erupted in normal functional occlusion with natural antagonist and adjacent teeth
Exclusion Criteria:
- Participants with general/systemic illness. 2- Pregnant or lactating females. 3- Concomitant participation in another research study. 4- Inability to comply with study procedures. 5- Heavy bruxism habits. 6- Last experience with allergic reactions against any components of the used materials.
7- Patients receiving orthodontic treatment.
Tooth exclusion:
- Teeth with clinical symptoms of pulpitis such as spontaneous pain or sensitivity to pressure.
- Non-vital teeth, Fractured or cracked teeth.
- Secondary carious lesions.
- Hypocalcified or hypoplastic teeth.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: "SPRG-based" Resin Composite. (BEAUTIFIL II, Shofu Inc. Kyoto, Japan).
A fluoride releasing, highly aesthetic dental material for all classes of restorations with S-PRG (Surface Pre-reacted Glass Ionomer) technology in regards to it's ability to recharge fluoride and appropriate for patients with a high caries index.
|
A fluoride releasing, highly aesthetic dental material that is S-PRG (Surface Pre-reacted Glass Ionomer) based , has the ability to recharge fluoride and appropriate for patients with a high caries index.
|
|
Experimental: "Alkasite-based" restoration. (Cention N)
Cention N offers tooth-coloured esthetics together with high flexural strength.
The new filling material belongs to the materials group of Alkasites.
The patented alkaline filler increases the release of hydroxide ions to regulate the pH value during acid attacks.
As a result, demineralization can be prevented.
Moreover, the release of large numbers of fluoride and calcium ions forms a sound basis for the remineralization of dental enamel.
The initiator system enables good chemical self-curing.
|
Cention N offers tooth-coloured esthetics together with high flexural strength.
The new filling material belongs to the materials group of Alkasites.
The patented alkaline filler increases the release of hydroxide ions to regulate the pH value during acid attacks.
As a result, demineralization can be prevented.
Moreover, the release of large numbers of fluoride and calcium ions forms a sound basis for the remineralization of dental enamel.
The initiator system enables good chemical self-curing.
|
|
Active Comparator: Provisional RMGI(Fuji IX EXTRA),followed by nanohybrid resin composite(Neo Spectra® ST LV, Dentsply)
Traditional caries control technique by provisional Resin Modified Glass ionomer for 3 months period and then followed by removal and application of conventional nano hybrid composites.
|
GC Fuji IX GP® EXTRA is the fastest setting glass ionomer on the market.The faster final set saves valuable chair time which provides improved stability against water, an important feature in challenging oral environments. This product contains a next generation glass filler which elicits higher translucency, fluoride release, reactivity and a faster setting time. Then followed by Conventional Nano hybrid composite restoration(Neo Spectra® ST LV, Dentsply Sirona) which is nano-ceramic, light-cured, radiopaque, universal composite with novel SphereTEC filler technology.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative (hypersensitivity) and tooth vitality.
Time Frame: at baseline, 3 months, 6 months and 12 months.
|
Revised FDI Criteria for Biological properties and by scoring:
|
at baseline, 3 months, 6 months and 12 months.
|
|
Caries at restoration margin (CAR).
Time Frame: at baseline,3 months, 6 months and 12 months.
|
Revised FDI Criteria for Biological properties and by scoring:
|
at baseline,3 months, 6 months and 12 months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cost effectiveness
Time Frame: at baseline, 3 months, 6 months and 12 months.
|
A. Cost of single restoration at baseline (for both groups) (Mean, ±SD). B. Average cost per restoration after1 year (Mean, ±SD).
|
at baseline, 3 months, 6 months and 12 months.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 14422023456853
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on High Caries Risk Patients
-
Suez Canal UniversityCompletedHigh Caries Risk PatientsEgypt
-
Cairo UniversityUnknown
-
Cairo UniversityCompletedHigh Caries Risk Patients | Streptococcus MutansEgypt
-
Cairo UniversityCompletedCaries | Side Effect | High Caries Risk Patients | Antimicrobial EffectEgypt
-
Cairo UniversityUnknownHigh Caries Risk Patients | Antimicrobial Effect | Salivary pH | Patient Satisfaction to Taste
-
Cairo UniversityEnrolling by invitationClass V Dental Caries | High Caries Risk PatientsEgypt
-
Recep Tayyip Erdogan University Training and Research...CompletedHigh Caries Risk | Low Caries RiskTurkey
-
Centre Hospitalier Universitaire DijonTerminatedHigh Cardiovascular Risk Patients | Low Cardiovascular Risk PatientsFrance
-
Università Politecnica delle MarcheCompletedHigh-Risk Surgical PatientsItaly
-
Southeast University, ChinaRecruitingHigh-risk Patients | Risk Reduction | Machine LearningChina
Clinical Trials on "SPRG-based" Resin Composite : (BEAUTIFIL II, Shofu Inc. Kyoto, Japan).
-
Al-Azhar UniversityNot yet recruitingDental Caries | Primary Molars
-
Izmir Katip Celebi UniversityCompleted
-
Al-Azhar UniversityNot yet recruiting